Reply: Her2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus? [2]

British Journal of Cancer

Volumn 94, Issue 8, 2006, Pages 1214-1215

  Metges, J P ^a   Gibault, L ^b   Conan Charlet, V ^b   Lozac'H, P ^b   Robaszkiewicz, M ^b   Bessaguet, C ^b   Lagarde, N ^b   Volant, A ^b  

^a CHU MORVAN   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P53; STEM CELL FACTOR RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; DEVICE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOMA; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PLEURA EFFUSION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 33646139185     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603081     Document Type: Letter

References (15)

1. Akatmatsu M, Matsumato T, Oka K, Yamasaki S, Sonoue H, Kajiyama Y, Tsurumaru M, Sakai K (2003) c-erb2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 57: 1323-1327
2. Friess H, Fukuda A, Tang WH, Eichenberger A, Furlan N, Zimmermann A, Korc M, Buchler MW (1999) concommitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3. World J Surg 23: 1010-1018
3. Gibault L, Metges JP, Conan-Charlet V, Lozac'H P, Robaszkiewicz M, Bessaguet C, Lagarde N, Volant A (2005) Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer. Br J Cancer 93(1): 107-115
4. Hardwick RH, Barham CP, Ozua P, Newcomb PV, savage P, Powell R, Rahamin J, Alderson D (1997) Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma: no correlation with prognosis. Eur J Surg Oncol 23: 30-35
5. Metges JP, Guenet D, Codet JP, Moineau M, Volant A, Bizais Y, Robaszkiewicz M (2006) Potential significance of serum Her2/neu, EGFR, VEGf, IL6, and p53 in patients with esophageal squamous cell cancer (ESCC) treated by radiochemotherapy. Am Soc Clin Oncol Gastrointestinal cancers symposium, third Annual Meeting, San Francisco (abstract no. 45)
6. Mimura K, Kono K, Hanawa M, Mitsui F, Sugai H, Miyagawa N, Ooi A, Fujii H (2005b) frequencies of Her-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma. Br J Cancer 92: 1253-1260
7. Mimura K, Kono K, hanawa M, Kanzaki M, Nakao A, Ooi A, Fujii H (2005a) Trastuzumab-mediated antibody-dependent cellular cytotoxicity against esophageal squamous cell carcinoma. Clin Cancer Res 11: 4898-4904
8. Miyazono F, Metzger R, Warnecke-Eberz U, Baldus SE, Bradender J, Bollschweiler E, Doerfler W, Mueller RP, Dienes HP, Aikou T, Hoelscher AH, Scheider PM (2004) Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. Br J Cancer 91: 666-672
9. Penault-Llorca F, Balaton B, Sabourin JC, Le Doussal V (2002) Immunochemistry evaluation of HER2 status in infiltrating breast cancer: technical protocol and interpretation guidelines. Ann Pathol 22(2): 150-157, [French]
10. Sato S, Kajiyama Y, Sugano M, Iwanuma Y, Sonoue H, Matsumato T, Sasai K, Tsurumaru M (2005) Monoclonal antibody to HER-2/neu receptor enhances radiosensitivity of esophageal cancer cell lines expressing HER-2/neu oncoprotein. Int J Radiat Oncol Biol Phys 61: 203-211
11. Shiga K, Shiga C, Sasano H, Miyazaki S, Yamamoto T, Yamamoto M, Hayashi N, Nishihira T, Mori S (1993) expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression. Anticancer Res 13: 1293-1301
12. Sunpaweravong P, Sunpaweravong S, Puttawibul P, Mitarnun W, Zeng C, Baron AE, Franklin W, Said S, Varella-Garcia M (2005) Epidermal growth factor receptor and cyclinD1 are independently amplified and overexpressed in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 131: 111-119
13. Tanaka S, Mori M, Akiyoshi T, Tanaka Y, Mafune KI, Wands JR, Sugimachi K (1997) Coexpressionof Grb7 with epidermal growth factor receptor or HER2/erbB2 in human advanced esophageal carcinoma. Cancer Res 57: 28-31
14. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Belien JA, de Waal RM, Van Marck E, Magnani E, Weidner N, Harris AL, Dirix LY (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38: 1564-1579
15. Wang LS, Chow KC, Chi KH, Liu CC, Li WY, Chiu JH, Huang MH (1999) Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors. Am J Gastroenterol 94: 1933-1940